Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Marker Therapeutics, Inc.
| Metric | Marker Therapeutics, Inc. MRKRHealthcare |
|---|---|
| Quality Score | 42 / 100 |
| Revenue (latest) | $4M |
| Net income (latest) | −$12M |
| Operating margin | −363.5% |
| Net margin | −343.0% |
| Return on equity | −72.4% |
| Return on assets | −63.8% |
| Return on capital (ROCE) | −76.7% |
| Debt / equity | 0.14× |
| Revenue growth (YoY) | −46.2% |
| Altman Z″ (distress) | -69.50 |
| Accruals / assets | −0.8% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.